
IGI Inc.
About IGI Inc.
At IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and solid tumors through collaborations with other institutions including but not limited to other biotech companies, start-ups, investors and academia. We’re pioneering advancements in oncology that enhance the immune system’s ability to detect and kill cancer. Born from our patented BEAT® (Bispecific Engagement by Antibodies based on the T-cell receptor) technology platform, and ISB 2001 (BCMA x CD38 x CD3 trispecific antibody) is in development for patients with multiple myeloma.
Experience & capabilities
Browse companies by location
Similar Clinical Trial Sponsor companies in United States
AbbVie Inc.
Clinical Trial SponsorAcadia Pharmaceuticals
Clinical Trial SponsorAffyImmune Therapeutics, Inc.
Clinical Trial SponsorAffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform.